R Soeltl

Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.

Achim Krüger, R Soeltl, Igor Sopov et al. · PubMed · 2001 · 127 citations

Cancer Immunosurveillance, Oncology, Medicine +13

Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87)

Achim Krüger, R Soeltl, Verena Lutz et al. · Cancer Gene Therapy · 2000 · 59 citations

Tumor Biology, Medicine, Anti-cancer Agent +6

Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.

Della Porta P, R Soeltl, Krell Hw et al. · PubMed · 2000 · 42 citations

Esophageal Cancer, Human Esophageal, Pathology +19